A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer. - Hye Ryeon Kim; Su Jin Lee; Sehhoon Park; Hyun Ae Jung; Se-Hoon Lee; Han-Sin Jeong; Man Ki Chung; Myung-Ju Ahn (Cancer Research & Treatment, 2022)